Solu-Medrol

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Methylprednisolone sodium succinate

Disponible des:

Pfizer Australia Pty Ltd

clase:

Medicine Registered

Informació per a l'usuari

SOLU-MEDROL
®

_Methylprednisolone sodium succinate_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
Please read this leaflet carefully
before you start treatment with
SOLU-MEDROL. This leaflet
answers some common questions
about SOLU-MEDROL. It does not
contain all the available information
and it does not take the place of
talking to your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you being treated with
SOLU-MEDROL against the
benefits it is expected to have for
you.
Follow the instructions given to you
by your doctor and the advice
contained in this leaflet.
IF YOU HAVE ANY CONCERNS ABOUT
BEING TREATED WITH THIS MEDICINE,
ASK YOUR DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET.
You may need to read it again.
WHAT SOLU-MEDROL
IS USED FOR
Your doctor has prescribed SOLU-
MEDROL for the treatment of one or
more of the following:
•
skin diseases
•
allergic reactions
•
inflammation of the eyes
•
respiratory diseases and certain
respiratory infections
•
diseases of the gut
(gastrointestinal tract)
•
multiple sclerosis
•
rheumatic disorders
•
diseases of the blood
•
treatment of certain glandular
conditions
Your doctor may have prescribed
SOLU-MEDROL for another reason.
_HOW YOUR MEDICINE WORKS_
Methylprednisolone sodium
succinate, the active ingredient in
SOLU-MEDROL, belongs to a group
of medicines called corticosteroids.
SOLU-MEDROL acts in the body by
reducing inflammation (pain,
swelling, redness and heat), which is
one of the body's reactions to injury,
and by reducing the body's reaction
to infection.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY SOLU-
MEDROL HAS BEEN PRESCRIBED FOR
YOU.
SOLU-MEDROL is available only
with a doctor's prescription.
There is no evidence that SOLU-
MEDROL is addictive.
BEFORE YOU START
TREATMENT WITH SOLU-
MEDROL
WHEN YOU MUST NOT TAKE IT
•
Do not take SOLU-MEDROL if
you have an allergy to:SOLU-
MEDROL or other medicines
containing methylprednisolone
•
any of the ingredients listed at

Fitxa tècnica

Version: pfpsolmv10813 
Supersedes: pfpsolmv10212 

Page 1 of 22

PRODUCT INFORMATION 
SOLU-MEDROL
®
 AND SOLU-MEDROL
®
 ACT-O-VIAL 
(METHYLPREDNISOLONE SODIUM SUCCINATE) 
POWDER FOR INJECTION 
For Intravenous or Intramuscular Use Only 
NAME OF THE MEDICINE 
Non-proprietary name: methylprednisolone sodium succinate 
Chemical structure: 

CAS number: 2375-03-3 
Molecular weight: 496.53 
DESCRIPTION 
Methylprednisolone  sodium  succinate,  USP,  occurs  as  a  white,  or  nearly  white,  odourless, 
hygroscopic,  amorphous  solid.    It  is  very  soluble  in  water  and  in  alcohol;  it  is  insoluble  in 
chloroform and is very slightly soluble in acetone. 
Methylprednisolone  sodium  succinate  is  so  extremely  soluble  in  water  that  it  may  be 
administered in a small volume of diluent and is especially well suited for intravenous use in 
situations in which high blood levels of methylprednisolone
are required rapidly. 
SOLU-MEDROL  is  available  in  several  strengths  and  packages  for  intravenous  or 
intramuscular administration. 
40 MG  ACT-O-VIAL
®
  SYSTEM  -  Each  mL  (when  mixed)  contains  methylprednisolone 
sodium  succinate  equivalent  to  40 mg  methylprednisolone;  also  1.6 mg  sodium  phosphate 
monobasic (anhydrous); 17.46 mg sodium phosphate dibasic
(anhydrous) and 25 mg lactose.   
125 MG  ACT-O-VIAL  SYSTEM  -  Each  2 mL  (when  mixed)  contains  methylprednisolone 
sodium  succinate  equivalent  to  125 mg  methylprednisolone;  also  1.6 mg  sodium  phosphate 
monobasic (anhydrous) and 17.4 mg sodium phosphate dibasic
(anhydrous). 
500 MG  VIAL  WITH  DILUENT  -  Each  8 mL  (when  mixed  as  directed)  contains 
methylprednisolone sodium succinate equivalent to  500 mg methylprednisolone; a